ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,637,475 | +15.8% | 693,616 | +53.7% | 0.01% | +20.0% |
Q2 2023 | $16,094,767 | +35.9% | 451,339 | -3.2% | 0.01% | +25.0% |
Q1 2023 | $11,843,474 | -42.3% | 466,278 | -7.8% | 0.00% | -42.9% |
Q4 2022 | $20,509,000 | +16.9% | 505,635 | -4.7% | 0.01% | +16.7% |
Q3 2022 | $17,543,000 | -7.4% | 530,773 | -1.4% | 0.01% | -14.3% |
Q2 2022 | $18,951,000 | -23.1% | 538,233 | +0.4% | 0.01% | 0.0% |
Q1 2022 | $24,656,000 | -31.7% | 536,131 | -1.5% | 0.01% | -30.0% |
Q4 2021 | $36,078,000 | +16.5% | 544,172 | +9.7% | 0.01% | 0.0% |
Q3 2021 | $30,977,000 | -24.9% | 496,197 | -0.4% | 0.01% | -23.1% |
Q2 2021 | $41,256,000 | +26.1% | 498,163 | +1.0% | 0.01% | +18.2% |
Q1 2021 | $32,711,000 | -10.4% | 493,306 | +3.7% | 0.01% | -15.4% |
Q4 2020 | $36,501,000 | +58.7% | 475,682 | -10.9% | 0.01% | +44.4% |
Q3 2020 | $22,998,000 | +21.9% | 534,059 | +22.3% | 0.01% | +12.5% |
Q2 2020 | $18,864,000 | +90.0% | 436,698 | +26.5% | 0.01% | +60.0% |
Q1 2020 | $9,930,000 | -56.7% | 345,165 | -4.5% | 0.01% | -50.0% |
Q4 2019 | $22,926,000 | +50.8% | 361,434 | -33.0% | 0.01% | +42.9% |
Q3 2019 | $15,199,000 | +9.7% | 539,365 | +3.2% | 0.01% | +16.7% |
Q2 2019 | $13,854,000 | +1385300.0% | 522,754 | +550167.4% | 0.01% | – |
Q4 2018 | $1,000 | -99.9% | 95 | -99.9% | 0.00% | -100.0% |
Q3 2018 | $1,438,000 | +821.8% | 75,064 | +552.7% | 0.00% | – |
Q2 2018 | $156,000 | -79.8% | 11,500 | -97.7% | 0.00% | – |
Q4 2016 | $771,000 | -79.3% | 498,385 | -1.6% | 0.00% | -100.0% |
Q3 2016 | $3,724,000 | +1.2% | 506,565 | -26.7% | 0.00% | 0.0% |
Q2 2016 | $3,679,000 | – | 690,795 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |